BARDA

Feb 07, 2024

Navigating the Healthcare Horizon: Odyssey of Mergers, Funding, and Acquisitions in 2024

Feb 23, 2021

Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Newsletter/Whitepaper